Population pharmacokinetics of pegaptanib sodium (Macugen<sup>&reg;</sup>) in patients with diabetic macular edema

Anthony S Basile; Matthew M Hutmacher; Kenneth G Kowalski; Kuan Y Gandelman; Dana J Nickens

doi:10.2147/OPTH.S74050

open access to scientific and medical research

Back to Journals » Clinical Ophthalmology » Volume 9

Original Research

Population pharmacokinetics of pegaptanib sodium (Macugen^®) in patients with diabetic macular edema

Total article views		HTML views	PDF downloads	Totals
11,910	Dovepress*	10,959+	1,782	12,741
	PubMed Central*	951	355	1,306
	Totals	11,910	2,137	14,047
*Since 16 February 2015 +Since July 2016

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.

Population pharmacokinetics of pegaptanib sodium (Macugen®) in patients with diabetic macular edema

Population pharmacokinetics of pegaptanib sodium (Macugen^®) in patients with diabetic macular edema